ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$40.92
+0.25 (+0.61%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+96.6% upside
Low Target
$62.72
Average Target
$80.43
High Target
$106.86
Current Price
$40.92
Current
$40.92
$40.92
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Scenario Analysis
Bear Case
$62.72
53.3%
Low target
Base Case
$80.43
+96.6%
Avg target
Bull Case
$106.86
+161.1%
High target
Risk/Reward
3.0x
Highly favorable
Price in Context
52-Week High
$42.50
-3.7% from high
52-Week Low
$19.62
+108.6% from low
50-Day SMA
$36.81
+11.2% vs SMA
200-Day SMA
$31.94
+28.1% vs SMA
RSI (14)
69.1
Neutral
Target vs 52W High
$80.43
+89.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.4% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +113.5% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.3% |
| MRNA | Hold | 31 | 32% | $149.45 | -42.1% |
| REGN | Buy | 36 | 72% | $76.80 | -91.6% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.5% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.3% |